Physician profile
Rajeev Joshi
NPI 1033282678
$29,011.41
in general payments reported to CMS, 2019-2025
38 companies · $8,551 in 2025
The $8,551 reported for 2025 was more than what 77% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,932 · 2020: $939 · 2021: $1,280 · 2022: $3,835 · 2023: $4,775 · 2024: $7,699 · 2025: $8,551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Travel and Lodging: $5,378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,646.92 |
| Travel and Lodging | $5,377.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,185.65 | 2019-2025 | Aveir, Ensite, Gallant |
| Boston Scientific Corporation | $7,506.19 | 2019-2025 | Farapulse, Ingevity Mri, Accolade Sr |
| Medtronic, INC. | $4,849.76 | 2021-2025 | Cobalt Dr Mri Surescan, Evera Mri Xt Dr Surescan, Micra |
| Impulse Dynamics (USA) INC. | $1,517.82 | 2021-2025 | Optimizer, Optimizer |
| Medtronic Vascular, INC. | $1,034.60 | 2019-2020 | |
| Biosense Webster, INC. | $685.23 | 2019-2025 | Carto 3 |
| E.R. Squibb & Sons, L.L.C. | $578.42 | 2020-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $513.96 | 2019-2025 | Lifevest |
| Atricure, INC. | $477.19 | 2021-2025 | Synergy Ablation System |
| Pfizer INC. | $467.84 | 2019-2025 | |
| Itamar Medical INC | $400.62 | 2022-2025 | Watchpatone |
| Novartis Pharmaceuticals Corporation | $355.30 | 2019-2025 | |
| Cardiva Medical, INC. | $314.62 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Cvrx, INC. | $284.51 | 2022-2024 | Barostim Neo System |
| Zoll Respicardia, INC. | $229.96 | 2021-2023 | Remede System |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $200.92 | 2022 | |
| Heartflow, INC. | $192.16 | 2021-2024 | |
| Edwards Lifesciences Corporation | $189.40 | 2019-2025 | Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $179.73 | 2019-2021 | |
| Kiniksa Pharmaceuticals, Ltd. | $94.26 | 2022-2023 | Arcalyst |
| Amgen INC. | $74.65 | 2019-2024 | |
| Kestra Medical Technology Services, INC. | $73.13 | 2025 | Assure Wcd |
| Innovation Technologies INC | $72.56 | 2023 | Irrisept |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.06 | 2019-2022 | |
| Bardy Diagnostics, INC. | $65.00 | 2019 | |
| Bridgebio Pharma, INC. | $47.93 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $44.98 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $40.10 | 2024 | |
| Merck Sharp & Dohme LLC | $38.83 | 2022-2023 | Verquvo |
| Medicomp INC | $38.44 | 2023 | Telepatch Cardiac Monitor |
| Sanofi-Aventis U.S. LLC | $35.92 | 2021-2023 | |
| Amarin Pharma, INC. | $31.48 | 2019-2021 | |
| Cordis US Corp. | $28.70 | 2024 | Mynx Venous Vcd |
| Actelion Pharmaceuticals US, INC. | $24.20 | 2024 | Opsumit, Uptravi |
| Esperion Therapeutics, INC. | $21.45 | 2021 | |
| Irhythm Technologies, INC. | $18.34 | 2019 | |
| Recor Medical INC | $16.51 | 2024 | Paradise Renal Denervation System |
| Abiomed | $15.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajeev Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.